|
Immunotherapy
Citations 91-100 of 577 total displayed.
|
Past content
(since Jun 2000):
|
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
- Claire L. Sutherland, Brian Rabinovich, N. Jan Chalupny, Pierre Brawand, Robert Miller, and David Cosman
Blood 2006; 108: 1313-1319.
[Abstract]
[Full text]
[PDF]
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIb antibodies
- Michelle Lee Webster, Ebrahim Sayeh, Min Crow, Pingguo Chen, Bernhard Nieswandt, John Freedman, and Heyu Ni
Blood 2006; 108: 943-946.
[Abstract]
[Full text]
[PDF]
Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25
- Zhuo Zhang, Meili Zhang, Kayhan Garmestani, Vladimir S. Talanov, Paul S. Plascjak, Barbara Beck, Carolyn Goldman, Martin W. Brechbiel, and Thomas A. Waldmann
Blood 2006; 108: 1007-1012.
[Abstract]
[Full text]
[PDF]
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
- Tobias Warger, Philipp Osterloh, Gerd Rechtsteiner, Melanie Fassbender, Valeska Heib, Beate Schmid, Edgar Schmitt, Hansjörg Schild, and Markus P. Radsak
Blood 2006; 108: 544-550.
[Abstract]
[Full text]
[PDF]
Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors
- Meili Zhang, Zhengsheng Yao, Zhuo Zhang, Kayhan Garmestani, Carolyn K. Goldman, Jeffrey V. Ravetch, John Janik, Martin W. Brechbiel, and Thomas A. Waldmann
Blood 2006; 108: 705-710.
[Abstract]
[Full text]
[PDF]
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
- Mats Brune, Sylvie Castaigne, John Catalano, Kurt Gehlsen, Anthony D. Ho, Wolf-Karsten Hofmann, Donna E. Hogge, Bo Nilsson, Reuven Or, Ana I. Romero, Jacob M. Rowe, Bengt Simonsson, Ruth Spearing, Edward A. Stadtmauer, Jeff Szer, Elisabeth Wallhult, and Kristoffer Hellstrand
Blood 2006; 108: 88-96.
[Abstract]
[Full text]
[PDF]
Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2-/- c-/- mice
- Nicolas Legrand, Tom Cupedo, Anja U. van Lent, Menno J. Ebeli, Kees Weijer, Thomas Hanke, and Hergen Spits
Blood 2006; 108: 238-245.
[Abstract]
[Full text]
[PDF]
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas
- John M. Pagel, Yukang Lin, Nathan Hedin, Anastasia Pantelias, Donald Axworthy, Diane Stone, Don K. Hamlin, D. Scott Wilbur, and Oliver W. Press
Blood 2006; 108: 328-336.
[Abstract]
[Full text]
[PDF]
Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes
- Béatrice Clémenceau, Nicolas Congy-Jolivet, Géraldine Gallot, Régine Vivien, Joëlle Gaschet, Gilles Thibault, and Henri Vié
Blood 2006; 107: 4669-4677.
[Abstract]
[Full text]
[PDF]
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
- Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, Michel G. D. Kester, Inge Jedema, W. A. Erik Marijt, M. Ron Schaafsma, Roel Willemze, and J. H. Frederik Falkenburg
Blood 2006; 107: 4954-4960.
[Abstract]
[Full text]
[PDF]
|
|
